The Gross Margin of Marksans Pharma Ltd (MARKSANS.NS) is 53.13%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-03-31 | 53.13% |
| 2024-03-31 | 49.75% |
| 2023-03-31 | 50.25% |
| 2022-03-31 | 49.83% |
| 2021-03-31 | 55.05% |
| 2020-03-31 | 47.87% |
| 2019-03-31 | 46.33% |
| 2018-03-31 | 39.07% |
| 2017-03-31 | 37.19% |
| 2016-03-31 | 39.90% |